Pieris Pharmaceuticals (PIRS) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

PIRS is expected to report earnings to fall 320.00% to -10 cents per share on November 08

Pieris Pharmaceuticals PIRS Stock Earnings Reports

Q3'23

Est.

$-0.11

Q2'23

Beat

by $0.21

Q1'23

Est.

$-0.18

Q4'22

Beat

by $0.12

Q3'22

Beat

by $0.03

The last earnings report on August 03 showed earnings per share of 5 cents, beating the estimate of -15 cents. With 26.49K shares outstanding, the current market capitalization sits at 21.34M.

View a ticker or compare two or three

Compare

PIRS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For PIRS
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of an anticalin-brand protein technology

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

225 Franklin Street

Phone

+1 857 246-8998

Employees

Web

https://www.pieris.com